Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19

OBJECTIVES: Coronavirus disease 2019 (COVID‐19) is rapidly spreading worldwide. Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19. This study is aimed to discover its molecular mechanism and provide potential drug targets. MATERIALS AND METHODS: An LQC target and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Prolif
Egile Nagusiak: Xia, Qi‐Dong, Xun, Yang, Lu, Jun‐Lin, Lu, Yu‐Chao, Yang, Yuan‐Yuan, Zhou, Peng, Hu, Jia, Li, Cong, Wang, Shao‐Gang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Original Manuscripts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705900/
https://ncbi.nlm.nih.gov/pubmed/33140889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12949
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak